Article
Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease.
Journal of the neurological sciences - 1 May 1995
Hantaï D, Akaaboune M, Lagord C, Murawsky M, Houenou L J, Festoff B W, Vaught J L, Rieger F, Blondet B
Abstract excerpt
Recombinant human insulin-like growth factor-I (IGF-I) is being considered as a possible therapeutic agent for the treatment of motoneuron diseases like amyotrophic lateral sclerosis. The neurological mutant mouse wobbler, carries an autosomal recessive gene (wr) and has been characterized as a model of lower motoneuron disorders with associated muscle atrophy, denervation and reinnervation. The purpose of the...
Topics
- Animals
- Body Weight
- Choline O-Acetyltransferase
- Hand Strength
- Humans
- Insulin-Like Growth Factor I
- Mice
- Mice, Inbred C57BL
- Mice, Neurologic Mutants
- Motor Neuron Disease
- Muscles
